Director/PDMR Shareholding

RNS Number : 3902X

GlaxoSmithKline PLC

18 December 2019

 

GlaxoSmithKline plc (the 'Company')

Transaction notification

1.	Details of PDMR/person closely associated with them ('PCA')
a)	Name	Mr R Simard
b)	Position/status	President, Pharmaceuticals Supply Chain
c)	Initial notification/ amendment	Initial notification
2.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)	Name	GlaxoSmithKline plc
b)	LEI	5493000HZTVUYLO1D793
3.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted
a)	Description of the financial instrument	Ordinary shares of 25 pence each ('Ordinary Shares') ISIN: GB0009252882
b)	Nature of the transaction	Following the final vesting on 16 December 2019 of an award made on 13 December 2013 under the GlaxoSmithKline Deferred Investment Award programme, Mr Simard will receive a cash payment of £60,237.79 less applicable tax withholding in respect of 3,414.453 notional Ordinary Shares.
c)	Price(s) and volume(s)		Price(s)	Volume(s)
			£17.642	3,414.453
d)	Aggregated information	N/A (single transaction)
	Aggregated volume Price
e)	Date of the transaction	2019-12-16
f)	Place of the transaction	N/A

 

END

 

 

DSHQVLFFKLFEFBZ